Day Trading Goal
  • Investing
  • Economy
  • Editor’s Pick
  • Latest News
  • Investing
  • Economy
  • Editor’s Pick
  • Latest News
No Result
View All Result
Day Trading Goal
No Result
View All Result
Home Latest News

WATCH: Parody drug ad spotlights RFK’s crackdown on misleading pharmaceutical marketing

admin by admin
September 19, 2025
in Latest News
0
WATCH: Parody drug ad spotlights RFK’s crackdown on misleading pharmaceutical marketing
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Shortly after announcing a strategy to go after deceptive direct-to-consumer advertising by the pharmaceutical industry, Robert F. Kennedy Jr. and the Department of Health and Human Services released a parody video of a drug advertisement – a pointed way of emphasizing the fact that the United States is largely unique in allowing drug ads.

‘Tired of endless drug ads promising quick fixes but leaving you sicker than you were before? That can change today. Ask your doctor about MAHA,’ the parody commercial begins, referring to Kennedy’s ‘Make America Healthy Again’ initiative. 

‘MAHA may cause healthier living, fewer chronic diseases, and lower drug costs,’ the video’s narrator continues. ‘Some Americans reported more time spent with family instead of at the pharmacy. Other side effects may include healthier children, a stronger nation, more transparency in healthcare, honest advertising, and accountability from Big Pharma.’

The drug advertisement parody comes after Kennedy and HHS laid out their plans to target direct-to-consumer drug advertising – something that isn’t widely allowed outside the United States – in a new children’s health strategy released earlier this month. 

The strategy said it will ramp up enforcement of current prescription drug advertising laws, with a priority on ‘egregious violations demonstrating harm from current practices.’ The strategy noted these violations could include the dissemination of ‘risk information and quality of life through misleading and deceptive advertising on social media and digital platforms.’

The strategy to go after direct-to-consumer drug ads will also include inter-agency cooperation to explore the development of potential new industry guidelines that limit direct-to-consumer advertising for certain ‘unhealthy foods’ to children. These efforts include ‘evaluating the use of misleading claims and imagery,’ the MAHA children’s strategy stated. 

Kennedy said alongside the release of HHS’s parody advertisement that the Trump administration plans to begin holding the pharmaceutical industry accountable for not sharing full safety information in their drug ads on television, radio and beyond.

 

‘No more hiding vital information in small print, or pushing it off to a website, or a 1-800 number,’ Kennedy said in a video released in conjunction with the parody advertisement. He also noted that regulators have been letting pharmaceutical manufacturers avoid providing complete warnings in their marketing materials.

Kennedy said in the accompanying video that, in the past, regulators let companies mention a vague ‘major statement’ of risk that required consumers to go elsewhere for important details about the drug. The secretary said this ‘loophole’ opened the door to a ‘tsunami’ of misleading advertisements.

‘Drug ads drove up prescription drug costs and distorted doctor-patient conversations. Patients saw glossy ads and often asked for new medications,’ Kennedy continued. ‘Big Pharma’s marketing hooked the country on prescription drugs. We’re taking action to end that practice.’

This post appeared first on FOX NEWS

Previous Post

SCOOP: Ilhan Omar hit with House Ethics complaint over response to Charlie Kirk’s assassination

Next Post

Hunter Biden was involved in pardon talks toward end of father’s term, source says

Next Post
Hunter Biden was involved in pardon talks toward end of father’s term, source says

Hunter Biden was involved in pardon talks toward end of father’s term, source says

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • Trending
    • Comments
    • Latest
    Thatcher at 100: Lessons in civility, strength and enduring alliances

    Thatcher at 100: Lessons in civility, strength and enduring alliances

    October 13, 2025
    ASML share price forecast after earnings: buy or sell?

    ASML share price forecast after earnings: buy or sell?

    October 15, 2025
    Trump ally Ben Carson sworn in as national advisor for nutrition, health, and housing with USDA

    Trump ally Ben Carson sworn in as national advisor for nutrition, health, and housing with USDA

    September 25, 2025
    Top crypto price predictions: Avantis, Lista DAO, Aevo

    Top crypto price predictions: Avantis, Lista DAO, Aevo

    September 21, 2025
    Top 4 catalysts for the blue-chip CAC 40 Index this week

    Top 4 catalysts for the blue-chip CAC 40 Index this week

    0
    Top catalysts for Canada’s TSX Composite Index

    Top catalysts for Canada’s TSX Composite Index

    0
    Weekly wrap: markets rally, Charlie Kirk murder, iPhone 17 launch and PMs resign

    Weekly wrap: markets rally, Charlie Kirk murder, iPhone 17 launch and PMs resign

    0
    These 3 undervalued stocks are poised for a rally in the final quarter of 2025

    These 3 undervalued stocks are poised for a rally in the final quarter of 2025

    0
    Top 4 catalysts for the blue-chip CAC 40 Index this week

    Top 4 catalysts for the blue-chip CAC 40 Index this week

    October 20, 2025
    Here’s why Japan’s Nikkei 225 Index is in a bull run

    Here’s why Japan’s Nikkei 225 Index is in a bull run

    October 20, 2025
    Top 3 altcoins to buy as signs of a crypto bull run emerge

    Top 3 altcoins to buy as signs of a crypto bull run emerge

    October 20, 2025
    Carnival share price forecast as the cruising boom intensifies

    Carnival share price forecast as the cruising boom intensifies

    October 20, 2025

    Recent News

    Top 4 catalysts for the blue-chip CAC 40 Index this week

    Top 4 catalysts for the blue-chip CAC 40 Index this week

    October 20, 2025
    Here’s why Japan’s Nikkei 225 Index is in a bull run

    Here’s why Japan’s Nikkei 225 Index is in a bull run

    October 20, 2025
    Top 3 altcoins to buy as signs of a crypto bull run emerge

    Top 3 altcoins to buy as signs of a crypto bull run emerge

    October 20, 2025
    Carnival share price forecast as the cruising boom intensifies

    Carnival share price forecast as the cruising boom intensifies

    October 20, 2025

    Popular News

    Top 4 catalysts for the blue-chip CAC 40 Index this week

    Top 4 catalysts for the blue-chip CAC 40 Index this week

    October 20, 2025
    Here’s why Japan’s Nikkei 225 Index is in a bull run

    Here’s why Japan’s Nikkei 225 Index is in a bull run

    October 20, 2025

    Latest News

    • Top 4 catalysts for the blue-chip CAC 40 Index this week
    • Here’s why Japan’s Nikkei 225 Index is in a bull run
    • Top 3 altcoins to buy as signs of a crypto bull run emerge
    • Carnival share price forecast as the cruising boom intensifies

    About DayTradingGoal

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 Daytradinggoal.com All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Economy
    • Editor’s Pick
    • Latest News

    Copyright © 2025 Daytradinggoal.com All Rights Reserved.